The statistical software revolution in pharmaceutical development: challenges and opportunities in open source

• 1. Viraswami-Appanna et al. (2024). Accelerating drug development at Bristol Myers Squibb through innovation. Drug Discov Today. • 2. Cook et al. (2014). Lessons from the fate of AstraZeneca’s drug pipeline. Nat Rev Drug Discov. • 3. Pammolli et al. (2011). The productivity crisis in pharmaceutical R&D. Nat Rev Drug Discov. • 4. Laermann-Nguyen & Backfisch (2021). Innovation crisis in the pharmaceutical industry? SN Bus Econ.5. Schlander et al. (2021). Cost of researching and developing a new drug: A systematic review. Pharmacoeconomics. Open-source statistical software development is increasingly the preferred solution for leveraging new statistical methods in the pharmaceutical industry. However, with a…

• MR
  Medical Research Council

  Award: MC_UU_00040/03